Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice

Human Molecular Genetics

Volumn 23, Issue 25, 2014, Pages 6903-6915

  Accornero, Federica ^a   Kanisicak, Onur ^a   Tjondrokoesoemo, Andoria ^a   Attia, Aria C ^a   McNally, Elizabeth M ^b   Molkentin, Jeffery D ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UChicago Medicine   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN, CROTOXIN DRUG COMBINATION; COBROTOXIN; CROTOXIN; DRUG COMBINATION; METALLOTHIONEIN; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; SARCOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL; CELL MEMBRANE; DEFICIENCY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; MUSCLE FIBRIL; MUSCULAR DYSTROPHY; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CELL MEMBRANE; COBRA CARDIOTOXIN PROTEINS; CROTOXIN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MUSCULAR DYSTROPHIES; MUTATION; MYOFIBRILS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SARCOGLYCANS; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 84941758541     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu413     Document Type: Article

References (57)

1. Wallace, G.Q. and McNally, E.M. (2009) Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu. Rev. Physiol., 71, 37–57.
2. Cohn, R.D., van Erp, C., Habashi, J.P., Soleimani, A.A., Klein, E.C., Lisi, M.T., Gamradt, M., ap Rhys, C.M., Holm, T.M., Loeys, B.L. et al. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med., 13, 204 – 210.
3. Merly, F., Lescaudron, L., Rouaud, T., Crossin, F. and Gardahaut, M.F. (1999) Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve, 22, 724–732.
4. Lescaudron, L., Peltekian, E., Fontaine-Perus, J., Paulin, D., Zampieri, M., Garcia, L. and Parrish, E. (1999) Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul. Disord., 9, 72 – 80.
5. Brunelli, S. and Rovere-Querini, P. (2008) The immune system and the repair of skeletal muscle. Pharmacol. Res., 58, 117–121.
6. Iannaccone, S., Quattrini, A., Smirne, S., Sessa, M., de Rino, F., Ferini-Strambi, L. and Nemni, R. (1995) Connective tissue proliferation and growth factors in animal models of Duchenne muscular dystrophy. J. Neurol. Sci., 128, 36 – 44.
7. Murakami, N., McLennan, I.S., Nonaka, I., Koishi, K., Baker, C. and Hammond-Tooke, G. (1999) Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve, 22, 889–898.
8. Sun, G., Haginoya, K., Dai, H., Chiba, Y., Uematsu, M., Hino-Fukuyo, N., Onuma, A., Iinuma, K. and Tsuchiya, S. (2009) Intramuscular renin-angiotensin system is activated in human muscular dystrophy. J. Neurol. Sci., 280, 40–48.
9. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Cornelio, F., Morandi, L. and Mantegazza, R. (1995) Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest., 96, 1137 – 1144.
10. Brooke, B.S., Habashi, J.P., Judge, D.P., Patel, N., Loeys, B. and Dietz, H.C. 3rd. (2008) Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N. Engl. J. Med., 358, 2787 – 2795.
11. Andreetta, F., Bernasconi, P., Baggi, F., Ferro, P., Oliva, L., Arnoldi, E., Cornelio, F., Mantegazza, R. and Confalonieri, P. (2006) Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy. J. Neuroimmunol., 175, 77 – 86.
12. Wynn, T.A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest., 117, 524–529.
13. Olson, E.N., Sternberg, E., Hu, J.S., Spizz, G. and Wilcox, C. (1986) Regulation of myogenic differentiation by type beta transforming growth factor. J. Cell Biol., 103, 1799–1805.
14. Charge, S.B. and Rudnicki, M.A. (2004) Cellular and molecular regulation of muscle regeneration. Physiol. Rev., 84, 209–238.
15. Li, Y., Foster, W., Deasy, B.M., Chan, Y., Prisk, V., Tang, Y., Cummins, J. and Huard, J. (2004) Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol., 164, 1007 – 1019.
16. Allen, R.E. and Boxhorn, L.K. (1987) Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J. Cell Physiol., 133, 567 – 572.
17. Kollias, H.D. and McDermott, J.C. (2008) Transforming growth factor-beta and myostatin signaling in skeletal muscle. J. Appl. Physiol., 104, 579 – 587.
18. Mu, X. and Li, Y. (2011) Conditional TGF-beta1 treatment increases stem cell-like cell population in myoblasts. J. Cell Mol. Med., 15, 679–690.
19. Yamazaki, M., Minota, S., Sakurai, H., Miyazono, K., Yamada, A., Kanazawa, I. and Kawai, M. (1994) Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am. J. Pathol., 144, 221–226.
20. Brand, T., MacLellan, W.R. and Schneider, M.D. (1993) A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J. Biol. Chem., 268, 11500 – 11503.
21. Yoo, B.M., Yeo, M., Oh, T.Y., Choi, J.H., Kim, W.W., Kim, J.H., Cho, S.W., Kim, S.J. and Hahm, K.B. (2005) Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas, 30, e71 – e79.
22. Chen, Y.F., Feng, J.A., Li, P., Xing, D., Zhang, Y., Serra, R., Ambalavanan, N., Majid-Hassan, E. and Oparil, S. (2006) Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. J. Appl. Physiol., 100, 564 – 571.
23. Durbeej, M. and Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev., 12, 349 – 361.
24. Hack, A.A., Lam, M.Y., Cordier, L., Shoturma, D.I., Ly, C.T., Hadhazy, M.A., Hadhazy, M.R., Sweeney, H.L. and McNally, E.M. (2000) Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J. Cell Sci., 113(Pt 14), 2535 – 2544.
25. Burks, T.N. and Cohn, R.D. (2011) Role of TGF-beta signaling in inherited and acquired myopathies. Skelet. Muscle, 1, 19.
26. Relaix, F. and Zammit, P.S. (2012) Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development, 139, 2845 – 2856.
27. Leung, Y.K., Pankhurst, M., Dunlop, S.A., Ray, S., Dittmann, J., Eaton, E.D., Palumaa, P., Sillard, R., Chuah, M.I., West, A.K. et al. (2010) Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways. Exp. Neurol., 221, 98–106.
28. Leung, J.Y., Bennett, W.R., Herbert, R.P., West, A.K., Lee, P.R., Wake, H., Fields, R.D., Chuah, M.I. and Chung, R.S. (2012) Metallothionein promotes regenerative axonal sprouting of dorsal root ganglion neurons after physical axotomy. Cell Mol. Life Sci., 69, 809 – 817.
29. Ruttkay-Nedecky, B., Nejdl, L., Gumulec, J., Zitka, O., Masarik, M., Eckschlager, T., Stiborova, M., Adam, V. and Kizek, R. (2013) The role of metallothionein in oxidative stress. Int. J. Mol. Sci., 14, 6044–6066.
30. Terrill, J.R., Radley-Crabb, H.G., Iwasaki, T., Lemckert, F.A., Arthur, P.G. and Grounds, M.D. (2013) Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. FEBS J., 280, 4149 – 4164.
31. Jung, C., Martins, A.S., Niggli, E. and Shirokova, N. (2008) Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc. Res., 77, 766–773.
32. Ambjorn, M., Asmussen, J.W., Lindstam, M., Gotfryd, K., Jacobsen, C., Kiselyov, V.V., Moestrup, S.K., Penkowa, M., Bock, E. and Berezin, V. (2008) Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J. Neurochem., 104, 21–37.
33. Ikushima, H. and Miyazono, K. (2011) Biology of transforming growth factor-beta signaling. Curr. Pharm. Biotechnol., 12, 2099–2107.
34. Ceco, E. and McNally, E.M. (2013) Modifying muscular dystrophy through transforming growth factor-beta. FEBS J., 280, 4198 – 4209.
35. Heydemann, A., Ceco, E., Lim, J.E., Hadhazy, M., Ryder, P., Moran, J.L., Beier, D.R., Palmer, A.A. and McNally, E.M. (2009) Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Invest., 119, 3703–3712.
36. Cencetti, F., Bernacchioni, C., Tonelli, F., Roberts, E., Donati, C. and Bruni, P. (2013) TGFbeta1 evokes myoblast apoptotic response via a novel signaling pathway involving S1P4 transactivation upstream of Rho-kinase-2 activation. FASEB J., 27, 4532 – 4546.
37. Li, X., McFarland, D.C. and Velleman, S.G. (2009) Transforming growth factor-beta1-induced satellite cell apoptosis in chickens is associated with beta1 integrin-mediated focal adhesion kinase activation. Poult. Sci., 88, 1725–1734.
38. Wissing, E.R., Boyer, J.G., Kwong, J.Q., Sargent, M.A., Karch, J., McNally, E.M., Otsu, K. and Molkentin, J.D. (2014) P38alpha MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism. Hum. Mol. Genet., doi: 10.1093/hmg/ddu270.
39. Sinha-Hikim, I., Braga, M., Shen, R. and Sinha Hikim, A.P. (2007) Involvement of c-Jun NH2-terminal kinase and nitric oxide-mediated mitochondria-dependent intrinsic pathway signaling in cardiotoxin-induced muscle cell death: role of testosterone. Apoptosis, 12, 1965 – 1978.
40. Zimowska, M., Duchesnay, A., Dragun, P., Oberbek, A., Moraczewski, J. and Martelly, I. (2009) Immunoneutralization of TGFbeta1 improves skeletal muscle regeneration: effects on myoblast differentiation and glycosaminoglycan content. Int. J. Cell Biol., 2009, 659372.
41. Fakhfakh, R., Lamarre, Y., Skuk, D. and Tremblay, J.P. (2012) Losartan enhances the success of myoblast transplantation. Cell Transplant, 21, 139–152.
42. Schwander, M., Leu, M., Stumm, M., Dorchies, O.M., Ruegg, U.T., Schittny, J. and Muller, U. (2003) Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev. Cell, 4, 673–685.
43. Sharma, K., Cook, A., Smith, M., Valancius, C. and Inscho, E.W. (2005) TGF-beta impairs renal autoregulation via generation of ROS. Am. J. Physiol. Renal Physiol., 288, F1069–F1077.
44. Hagler, M.A., Hadley, T.M., Zhang, H., Mehra, K., Roos, C.M., Schaff, H.V., Suri, R.M. and Miller, J.D. (2013) TGF-beta signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovasc. Res., 99, 175 – 184.
45. Yang, L., Qu, M., Wang, Y., Duan, H., Chen, P., Wang, Y., Shi, W., Danielson, P. and Zhou, Q. (2013) Trichostatin A inhibits transforming growth factor-beta-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling. Mol. Pharmacol., 83, 671–680.
46. Hsieh, H.L., Wang, H.H., Wu, W.B., Chu, P.J. and Yang, C.M. (2010) Transforming growth factor-beta1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-kappaB pathways. J. Neuroinflammation, 7, 88.
47. Santos, C.R., Martinho, A., Quintela, T. and Goncalves, I. (2012) Neuroprotective and neuroregenerative properties of metallothioneins. IUBMB Life, 64, 126–135.
48. Ceylan-Isik, A.F., Zhao, P., Zhang, B., Xiao, X., Su, G. and Ren, J. (2010) Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J. Mol. Cell. Cardiol., 48, 367–378.
49. Oshima, Y., Fujio, Y., Nakanishi, T., Itoh, N., Yamamoto, Y., Negoro, S., Tanaka, K., Kishimoto, T., Kawase, I. and Azuma, J. (2005) STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc. Res., 65, 428–435.
50. Lim, K.S., Cha, M.J., Kim, J.K., Park, E.J., Chae, J.W., Rhim, T., Hwang, K.C. and Kim, Y.H. (2013) Protective effects of protein transduction domain-metallothionein fusion proteins against hypoxia- and oxidative stress-induced apoptosis in an ischemia/reperfusion rat model. J. Control Release, 169, 306–312.
51. Nielsen, A.E., Bohr, A. and Penkowa, M. (2007) The balance between life and death of cells: roles of metallothioneins. Biomark. Insights, 1, 99–111.
52. Malik, V., Rodino-Klapac, L.R. and Mendell, J.R. (2012) Emerging drugs for Duchenne muscular dystrophy. Expert Opin. Emerg. Drugs, 17, 261–277.
53. De Luca, A. (2012) Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. Acta Myol., 31, 40–47.
54. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I. and Davies, K.E. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature, 384, 349 – 353.
55. Accornero, F., van Berlo, J.H., Benard, M.J., Lorenz, J.N., Carmeliet, P. and Molkentin, J.D. (2011) Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ. Res., 109, 272 – 280.
56. Cai, C., Masumiya, H., Weisleder, N., Matsuda, N., Nishi, M., Hwang, M., Ko, J.K., Lin, P., Thornton, A., Zhao, X. et al. (2009) MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol., 11, 56–64.
57. Millay, D.P., Sargent, M.A., Osinska, H., Baines, C.P., Barton, E.R., Vuagniaux, G., Sweeney, H.L., Robbins, J. and Molkentin, J.D. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med., 14, 442 – 447.